BioEclipse Therapeutics (Series A-1)
Funding Details
- Awarder
- Inbox
- Date Award
- June 25, 2019
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $7,700,000
Company Info
- Organizations Involved
- Johnson & Johnson Innovation
- Founders
- Pamela Contag
- Company Description
- BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
- Market
- Cancer treatment
- Location
- South San Francisco, California, USA
- Coinvestors
- DEFTA Partners, Plum Alley Investments, Revelis Capital Group, TEEC Angel Fund, Tsingyuan Ventures